Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2021
Source ID
10.1016/j.vaccine.2021.04.031

Entities

People

  • Burc Barin
  • Caroline E. English
  • David R. Tribble
  • Eugene V Millar
  • Jason W. Bennett
  • John P. Hennessey
  • M. Timothy Cooke
  • Michael M. Schwartz
  • Michael W. Ellis
  • Natasha N. Law
  • Patrick M. Carey
  • Terrence Cochrane

Organizations

  • Defense Health Agency
  • National Institute of Allergy and Infectious Diseases

Tags

Technology Areas

  • Biotechnology